03:41 AM EDT, 08/30/2024 (MT Newswires) -- Mountain Crest Acquisition Corp. V ( MCAG ) and CUBEBIO said late Thursday they have agreed to a business combination deal.

Mountain Crest, a blank-check company, and the South Korean cancer detection biotechnology firm said they plan to list CUBEBIO on the Nasdaq stock market and hope to complete the combination in Q1 2025.

Under the agreement, the pre-transaction equity value for CUBEBIO is $375 million, the companies said.